GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Oriental Bioengineering Inc (OTCPK:AOBI) » Definitions » Debt-to-Revenue

American Oriental Bioengineering (American Oriental Bioengineering) Debt-to-Revenue : 1.29 (As of Sep. 2013)


View and export this data going back to 1991. Start your Free Trial

What is American Oriental Bioengineering Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

American Oriental Bioengineering's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2013 was $87.7 Mil. American Oriental Bioengineering's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2013 was $5.1 Mil. American Oriental Bioengineering's annualized Revenue for the quarter that ended in Sep. 2013 was $71.7 Mil. American Oriental Bioengineering's annualized Debt-to-Revenue for the quarter that ended in Sep. 2013 was 1.29.


American Oriental Bioengineering Debt-to-Revenue Historical Data

The historical data trend for American Oriental Bioengineering's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oriental Bioengineering Debt-to-Revenue Chart

American Oriental Bioengineering Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.44 0.40 0.55 0.47

American Oriental Bioengineering Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.27 0.75 0.80 1.29

Competitive Comparison of American Oriental Bioengineering's Debt-to-Revenue

For the Biotechnology subindustry, American Oriental Bioengineering's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Oriental Bioengineering's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Oriental Bioengineering's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where American Oriental Bioengineering's Debt-to-Revenue falls into.



American Oriental Bioengineering Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

American Oriental Bioengineering's Debt-to-Revenue for the fiscal year that ended in Dec. 2012 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(67.088 + 0.555) / 145.1
=0.47

American Oriental Bioengineering's annualized Debt-to-Revenue for the quarter that ended in Sep. 2013 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(87.713 + 5.057) / 71.744
=1.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2013) Revenue data.


American Oriental Bioengineering Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


American Oriental Bioengineering (American Oriental Bioengineering) Business Description

Traded in Other Exchanges
N/A
Address
1 Liangshuihe First Ave, Beijing E-Town, Economic and Technology Development Area, E-Town, Beijing, CHN, 100176
Website
American Oriental Bioengineering Inc is a manufacturer of pharmaceutical and healthcare products. Its product line encompasses prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products.
Executives
Patti Cosimo J director AMERICAN ORIENTAL BIOENGINEERING, INC. 90 PARK AVENUE, 17TH FLOOR NEW YORK NY 10016

American Oriental Bioengineering (American Oriental Bioengineering) Headlines

No Headlines